By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pernix Therapeutics, Inc. 

P.O. Box 40

Gonzales  Louisiana  70707-0040  U.S.A.
Phone: 800-793-2145 Fax:



Company News
Pernix (PTX) Announces Reverse Stock Split And Corporate Governance Enhancements 10/13/2016 8:00:04 AM
Pernix (PTX) Announces Distribution Of TREXIMET 10/60 Mg (Sumatriptan 10mg And Naproxen Sodium 60 Mg) Dose For Use In Pediatric Patients 9/29/2016 11:50:23 AM
Marsha Stanton, Ph.D., RN, Pernix (PTX) Executive Director Of Medical And Government Affairs, Awarded Prestigious Pain Management Advocacy Award From The American Society For Pain Management Nursing 9/16/2016 8:00:24 AM
Pernix (PTX) Announces The Issuance Of Two New Orange Book Listed Patents For Zohydro ER With BeadTek 9/14/2016 10:13:16 AM
Pernix (PTX) Announces Significant Presence At PAINWeek 2016 9/9/2016 7:32:58 AM
Pernix (PTX) To Report Second Quarter 2016 Financial Results On August 11, 2016 8/4/2016 11:30:45 AM
Struggling Pernix (PTX) Shakes Up C-Suite, New CEO Named 7/27/2016 6:17:07 AM
Pernix (PTX) Axes 23% of Workforce in Restructuring to Save $10 Million Annually 7/7/2016 5:58:04 AM
Pernix (PTX) Announces Positive Phase IV Results Of Silenor Vs. Zolpidem Head-To-Head Arousability Study 6/16/2016 10:39:03 AM
Pernix (PTX) CEO Steps Down, Effectively Immediately 5/11/2016 6:41:43 AM